Multicenter Evaluation of a Self-Expanding Carotid Stent System with Distal Protection in the Treatment of Carotid Stenosis
M.D. Hilla,
W. Morrisha,
G. Soulezb,
A. Nevelsteenc,
G. Maleuxd,
C. Rogerse,f,
K.E. Hauptmanng,
A. Bonaféh,
R. Beyari,
L. Grubergi,
J. Schoferj for the MAVErIC International Investigators
a Calgary Stroke Program, Department of Clinical Neurosciences, University of Calgary, Calgary, Alberta, Canada
b Université de Montreal, Department of Radiology, CHUM-Notre Dame, Montréal, Québec, Canada
c Department of Vascular Surgery, University Hospital Gasthuisberg, Leuven, Belgium
d Center for Vascular Diseases, Section of Interventional Radiology, University Hospital Gasthuisberg, Leuven, Belgium
e Cardiovascular Division, Brigham and Womens Hospital, Boston, Mass
f Harvard-MIT Division of Health Sciences and Technology, Cambridge, Mass
g Krankenhaus der Barmherzigen Brüder, Trier, Germany
h Faculty of Medicine, Montpellier University Hospital Center, Montpellier-Nimes, France
i Division of Invasive Cardiology, Rambam Medical Center, Technion-Israel Institute of Technology, Haifa, Israel
j Center for Cardiology and Vascular Intervention, Hamburg, Germany

View larger version (42K):
[in a new window]
|
Fig 1. The Interceptor distal embolic protection device. A, Closed (0.0039-inch crossing profile). B, Open, showing the 1800-µm proximal openings.
| |

View larger version (13K):
[in a new window]
|
Fig 3. Particulate size distribution results compared with GuardWire+ positive controls.
| |

View larger version (92K):
[in a new window]
|
Fig 4. H&E staining of particulate demonstrating diverse cellular elements including macrophages and foam cells (200x).
| |